Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Walgreens Boots Alliance, Inc. (W8A.F)

Compare
9.95
-0.32
(-3.13%)
At close: 9:12:03 AM GMT+2
Loading Chart for W8A.F
  • Previous Close 10.27
  • Open 10.08
  • Bid --
  • Ask --
  • Day's Range 9.95 - 10.08
  • 52 Week Range 7.41 - 18.09
  • Volume 2,400
  • Avg. Volume 2,063
  • Market Cap (intraday) 8.675B
  • Beta (5Y Monthly) 0.64
  • PE Ratio (TTM) --
  • EPS (TTM) -9.49
  • Earnings Date Apr 8, 2025
  • Forward Dividend & Yield 0.95 (9.27%)
  • Ex-Dividend Date Nov 18, 2024
  • 1y Target Est --

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.

www.walgreensbootsalliance.com

193,000

Full Time Employees

August 31

Fiscal Year Ends

Recent News: W8A.F

View More

Performance Overview: W8A.F

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

W8A.F
8.01%
S&P 500 (^GSPC)
8.25%

1-Year Return

W8A.F
37.81%
S&P 500 (^GSPC)
3.55%

3-Year Return

W8A.F
69.43%
S&P 500 (^GSPC)
18.71%

5-Year Return

W8A.F
64.03%
S&P 500 (^GSPC)
116.85%

Compare To: W8A.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: W8A.F

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    8.96B

  • Enterprise Value

    36.30B

  • Trailing P/E

    --

  • Forward P/E

    7.18

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.06

  • Price/Book (mrq)

    0.96

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.87%

  • Return on Assets (ttm)

    0.55%

  • Return on Equity (ttm)

    -80.84%

  • Revenue (ttm)

    150.41B

  • Net Income Avi to Common (ttm)

    -8.83B

  • Diluted EPS (ttm)

    -9.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.19B

  • Total Debt/Equity (mrq)

    281.32%

  • Levered Free Cash Flow (ttm)

    4.33B

Research Analysis: W8A.F

View More

Company Insights: W8A.F

Research Reports: W8A.F

View More

People Also Watch